Hasil untuk "Nutritional diseases. Deficiency diseases"

Yuri Gardinazzi, Roger Gonzaléz March, Suprabhath Kalahasti et al.

Comorbidity networks, which capture disease-disease co-occurrence usually based on electronic health records, reveal structured patterns in how diseases cluster and progress across individuals. However, how these networks evolve across different age groups and how this evolution relates to properties like disease prevalence and mortality remains understudied. To address these issues, we used publicly available comorbidity networks extracted from a comprehensive dataset of 45 million Austrian hospital stays from 1997 to 2014, covering 8.9 million patients. These networks grow and become denser with age. We identified groups of diseases that exhibit similar patterns of structural centrality throughout the lifespan, revealing three dominant age-related components with peaks in early childhood, midlife, and late life. To uncover the drivers of this structural change, we examined the relationship between prevalence and degree. This allowed us to identify conditions that were disproportionately connected to other diseases. Using betweenness centrality in combination with mortality data, we further identified high-mortality bridging diseases. Several diseases show high connectivity relative to their prevalence, such as iron deficiency anemia (D50) in children, nicotine dependence (F17), and lipoprotein metabolism disorders (E78) in adults. We also highlight structurally central diseases with high mortality that emerge at different life stages, including cancers (C group), liver cirrhosis (K74), subarachnoid hemorrhage (I60), and chronic kidney disease (N18). These findings underscore the importance of targeting age-specific, network-central conditions with high mortality for prevention and integrated care.

Anthony J. Webster

There is a growing proportion of people with several disease conditions ("multimorbidity"), placing increasing demands on healthcare systems. One hypothesis is that clusters of diseases may arise from shared underlying disease processes (shared "pathogenesis"), whereby the presence of one disease indicates the state of disease progression to several related disease types. This article explains how this hypothesis can be tested using observational data for disease incidence. Specifically, a multistage model is used to test whether two diseases can have a "shared stage" or "step", before either disease can occur, and how the unobserved rate of this step can be determined. The approach offers a simple method for studying multiple diseases and identifying shared underlying causes of multiple conditions, and is illustrated with published data and numerical examples. The fundamental mathematical model is analysed to compare key statistical properties such as the expectation and variance with those of independent diseases. The main results do not need an understanding of the underlying mathematics and can be appreciated by a non-expert. Significance: It is widely believed that there are shared underlying pathways that can lead to several disease types (shared "pathogenesis"), and this may explain observed clusters of disease types. This article shows how this hypothesis can be tested for a pair or cluster of diseases, using observational data of disease incidence.

Xiao-Li Ren, Wei Chen, Ya Chen et al.

Abstract Background Immune-inflammatory deregulation in depression may contribute to elevated risk of subsequent mortality. While dietary omega-3 polyunsaturated fatty acids (PUFAs), particularly eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA), are known to confer neuroprotective effects for their anti-inflammatory properties, population-based evidence regarding their survival benefits and underlying mechanisms in depression remain scarce. This study aimed to investigate association between dietary omega-3 PUFAs and mortality risk in depressed individuals and identify immune-inflammatory mediation underlying mortality reductions. Methods Totally, 6,782 depressed individuals aged 20 years and above in 10 cycles (1999–2018) of the National Health and Nutrition Examination Survey (NHANES) were analyzed. Omega-3 PUFAs intake (total and individual) was assessed through 24-hour dietary recalls. Cox proportional hazard models were used to calculated hazard ratios (HRs) and 95% confidence intervals (CIs) for morality risk across omega-3 PUFA quartiles. Quantile-based g-computation model determined individual PUFA contributions, while mediation analysis evaluated the role of Geriatric Nutritional Risk Index (GNRI) and Systemic Immune-Inflammation Index (SII) in mortality reductions. Results Over the follow-up period of 679,294 person years, 1,281 deaths were documented. The HRs for the highest versus lowest quartile of omega-3 PUFAs were 0.76 (95% CI: 0.62, 0.94) for total mortality, 0.72 (95% CI: 0.50, 1.02) for CVD mortality, 0.82 (95% CI: 0.50, 1.35) for cancer mortality, and 0.77 (95% CI: 0.59, 1.00) for other-cause mortality. DPA showed the strongest association (58.40% weight for total mortality reduction, P = 0.002; 59.80% for other causes, P = 0.011), while EPA contributed most to cardiovascular mortality reductions (60.4%, P = 0.046). Mediation analysis revealed GNRI accounted for 8.1% of PUFA-mortality association (10.5% for DPA), with SII mediating 6.9% of DPA-specific benefit. Conclusion Higher intake of omega-3 PUFAs, predominantly EPA and DPA, were associated with a lower mortality risk in depressed individuals, partially mediated by immune-nutritional pathways. These findings underscore omega-3 PUFAs as potential dietary adjuncts for improving survival in depression through immunomodulation. Further long-term clinical studies are warranted to validate the survival benefits of omega-3 PUFAs in patients with depression.

Eduard Baladia, Manuel Moñino, Martina Miserachs et al.

Introduction: Perceptions and practices of healthcare professionals regarding the nutritional and dietary value of yogurt can play a crucial role in developing effective strategies to promote healthier and more sustainable dietary patterns. The aim of this study was to investigate the perceptions, attitudes, and practices of nutrition professionals regarding yogurt and its role in a healthy diet. Methods: A descriptive cross-sectional study involving 355 nutrition professionals in Spain was conducted. The survey was administered online and explored professionals' knowledge, attitudes, and practices regarding yogurt. Statistical analysis included descriptive and correlational techniques, with a significance level set at p < 0,05 to validate observations. Results: The study revealed that 62,8% of participants recognized yogurt as a key food in a healthy diet, while 31,8% adopted a neutral position. In addition to its nutritional contribution, over 80% associated yogurt consumption with the prevention or treatment of some health outcomes. The most important factors for recommending yogurt consumption were its nutritional value and demonstrated health benefits (96,1% and 70,1%, respectively). Knowledge about yogurt was significantly associated (p < 0,05) with a greater willingness to include it in the diet, and a positive attitude correlated with more intensive recommendation practices. Conclusions: The study unveils a predominantly positive attitude towards yogurt among nutrition professionals, supported by knowledge of its nutritional value and health benefits. The need for specific national guidelines and greater ongoing education to guide professionals and the population towards healthier and more sustainable practices was highlighted. Additionally, there is a future interest in considering the environmental sustainability of yogurt as an important factor for decision-making. Funding: This research has been funded by DANONE. PROTOCOL REGISTRATION: The research protocol was registered on the platform Open Science Framework (OSF): https://osf.io/ef97b

Samantha N. Atkinson, Caron Dean, Victoria L. Woyach et al.

Childhood and adolescent obesity and its associated morbidities are increasing in part due to the ingestion of diets high in fat (HFD). Changes in the gastrointestinal microbiome have been associated with these morbidities, including insulin resistance, cardiovascular disease, and inflammatory states. The use of dietary probiotics may mitigate these microbiome-associated morbidities and improve health during maturation. Using our established model of obesity in rats consuming an HFD from weaning, we examined the gut microbiome with a single-strain probiotic in the drinking water [<i>Lactiplantibacillus plantarum</i> 299v (Lp299v, LP299V^®)] of adolescent and adult rats. Our main finding was a differential effect of HFD and probiotic on the gut microbiome that was associated with maturation (adolescence vs. adulthood). Specifically, probiotic treatment of adolescent rats on an HFD led to alterations in the enrichment of the gut microbiome, which were associated with the morbidities of obesity, while adult rats under the same conditions exhibited minimal changes, demonstrating differences in plasticity associated with maturation. Of particular relevance in this regard is the fact that <i>Oscillospiraceae</i> and <i>Lachnospiraceae,</i> associated with beneficial short-chain fatty acid production, were enriched in adolescent rats on an HFD and treated with Lp299v. Our data suggest that the use of probiotics in childhood and adolescence may improve health in adulthood by potentially affecting the developing gastrointestinal microbiome.

Marco E Toc Sagra, Peter Weng, Diego V Bohórquez

Bin Xiao, Lina Fu, Zhe Yang et al.

Abstract Background This umbrella meta-analysis evaluates the effects of probiotics on cognitive function and metabolic health in Alzheimer’s disease (AD) and mild cognitive impairment (MCI) by synthesizing findings from meta-analyses of randomized controlled trials (RCTs), as existing evidence remains inconclusive. Methods A systematic search was conducted in PubMed, Web of Science, and Scopus to identify meta-analyses of RCTs investigating the impact of probiotic supplementation on cognitive function and metabolic biomarkers. The random-effects model was used. Heterogeneity and publication bias were assessed. Results Thirteen meta-analyses, comprising 3910 patients, were included. Probiotics significantly improved cognitive function in AD (SMD = 0.78, 95% CI: 0.33 to 1.23) and MCI (SMD = 0.43, 95% CI: 0.15 to 0.70). Probiotics also increased total antioxidant capacity (SMD = 0.40, 95% CI: 0.11 to 0.70) and reduced MDA (SMD =  − 0.35, 95% CI: − 0.62 to − 0.09) and hs-CRP (SMD =  − 0.59, 95% CI: − 0.87 to − 0.30). Insulin resistance improved, as reflected by decreased HOMA-IR (SMD =  − 0.34, 95% CI: − 0.43 to − 0.26). No significant effects were observed on glutathione, nitric oxide, or lipid profiles. Conclusion Probiotic supplementation appears to enhance cognitive function and metabolic parameters in individuals with MCI and AD, likely through mechanisms involving inflammation reduction, oxidative stress modulation, and improved insulin sensitivity. Further high-quality RCTs are required to validate these findings and determine optimal probiotic formulations.

Ning Wang, H. Tan, Sha Li et al.

Selenium is an essential mineral naturally found in soil, water, and some of the food. As an antioxidant, it is one of the necessary trace elements in human body and has been suggested as a dietary supplement for health benefit. Although the human body only needs a trace amount of selenium every day, plenty of recent studies have revealed that selenium is indispensable for maintaining normal functions of metabolism. In this study, we reviewed the antioxidant role of nutritional supplementation of selenium in the management of major chronic metabolic disorders, including hyperlipidaemia, hyperglycaemia, and hyperphenylalaninemia. Clinical significance of selenium deficiency in chronic metabolic diseases was elaborated, while clinical and experimental observations of dietary supplementation of selenium in treating chronic metabolic diseases, such as diabetes, arteriosclerosis, and phenylketonuria, were summarized. Toxicity and recommended dose of selenium were discussed. The mechanism of action was also proposed via inspecting the interaction of molecular networks and predicting target protein such as xanthine dehydrogenase in various diseases. Future direction in studying the role of selenium in metabolic disorders was also highlighted. In conclusion, highlighting the beneficial role of selenium in this review would advance our knowledge of the dietary management of chronic metabolic diseases.

Bimarsha Khanal, Paras Poudel, Anish Chapagai et al.

Plant diseases significantly impact our food supply, causing problems for farmers, economies reliant on agriculture, and global food security. Accurate and timely plant disease diagnosis is crucial for effective treatment and minimizing yield losses. Despite advancements in agricultural technology, a precise and early diagnosis remains a challenge, especially in underdeveloped regions where agriculture is crucial and agricultural experts are scarce. However, adopting Deep Learning applications can assist in accurately identifying diseases without needing plant pathologists. In this study, the effectiveness of various computer vision models for detecting paddy diseases is evaluated and proposed the best deep learning-based disease detection system. Both classification and detection using the Paddy Doctor dataset, which contains over 20,000 annotated images of paddy leaves for disease diagnosis are tested and evaluated. For detection, we utilized the YOLOv8 model-based model were used for paddy disease detection and CNN models and the Vision Transformer were used for disease classification. The average mAP50 of 69% for detection tasks was achieved and the Vision Transformer classification accuracy was 99.38%. It was found that detection models are effective at identifying multiple diseases simultaneously with less computing power, whereas classification models, though computationally expensive, exhibit better performance for classifying single diseases. Additionally, a mobile application was developed to enable farmers to identify paddy diseases instantly. Experiments with the app showed encouraging results in utilizing the trained models for both disease classification and treatment guidance.

Phenias Nsabimana, Befikadu Tariku Gutema, Kate Langley et al.

Abstract Background Economic growth in Rwanda is associated with significant changes in food systems, access to health and other services, lifestyle, and nutritional transitions. Nevertheless, our knowledge of dietary patterns in Rwanda remains limited. The present study aimed to identify the dietary habits of young adult population in Rwanda and to assess associated factors. Methods A developed and validated semi-quantitative food frequency questionnaire covering a one-year period was used to collect data on food intake of 1,218 participants (18–35 years old) from end of January to April 2023 in a cross-sectional study. Dietary habits were assessed using two indicators: the Global Diet Quality Score (GDQS) and dietary patterns. The latest was developed using exploratory factor analysis. Results Rwandan adults had a mean GDQS of 24.1; 64.4% had high GDQS, especially urban, and educated respondents. The Southern province led at 77.4%. Three dietary patterns were identified: “Modern” (high in processed foods and drinks), “Traditional” (rich in cereals, roots, and plant-based proteins), and “low variety” (low in diverse foods but high in sugar and salt). Dietary patterns significantly varied by residency, province, sex, age, social category, asset, and education level. Conclusion This study identified distinct dietary patterns among adult population of Rwanda, suggesting a nutritional transition associated with urbanization. The findings highlight the need for further research into the relationships between diet, obesity, and metabolic syndrome in Rwandan population.

Zi-ling Cai, Liao-yao Wang, Bing-yue Zhang et al.

Abstract Objective: This study aimed to evaluate the methodological quality of existing meta-analyses (MA) and the quality of evidence for outcome indicators to provide an updated overview of the evidence concerning the therapeutic efficacy of the Mediterranean diet (MD) for various types of CVD. Design: We conducted comprehensive searches of PubMed, Cochrane Library, and Embase databases. The quality of the MA was assessed using the A Measurement Tool to Assess Systematic Reviews 2 (AMSTAR 2) checklist, while the Grading of Recommendations Assessment, Development and Evaluation (GRADE) evidence evaluation system was employed to evaluate the quality of evidence for significant outcomes. Setting: The CVD remains a significant contributor to global mortality. Multiple MA have consistently demonstrated the efficacy of medical interventions in managing CVD. However, due to variations in the scope, quality and outcomes of these reviews, definitive conclusions are yet to be established. Participants: This study included five randomized trials and twelve non-randomized studies, with a combined participant population of 716 318. Results: The AMSTAR 2 checklist revealed that 54·55 % of the studies demonstrated high quality, while 9·09 % exhibited low quality, and 36·36 % were deemed critically low quality. Additionally, there was moderate evidence supporting a positive correlation between MD and CHD/acute myocardial infarction, stroke, heart failure, cardiovascular events, coronary events and major adverse cardiovascular events. Conclusions: This study indicates that although recognizing the potential efficacy of MD in managing CVD, the quality of the methodology and the evidence for the outcome indicators remain unsatisfactory.

Debora Fedele, A. de Francesco, S. Riso et al.

The world is currently facing the coronavirus disease (COVID-19) pandemic which places great pressure on health care systems and workers, often presents with severe clinical features, and sometimes requires admission into intensive care units. Derangements in nutritional status, both for obesity and malnutrition, are relevant for the clinical outcome in acute illness. Systemic inflammation, immune system impairment, sarcopenia, and preexisting associated conditions, such as respiratory, cardiovascular, and metabolic diseases related to obesity, could act as crucial factors linking nutritional status and the course and outcome of COVID-19. Nevertheless, vitamins and trace elements play an essential role in modulating immune response and inflammatory status. Overall, evaluation of the patient's nutritional status is not negligible for its implications on susceptibility, course, severity, and responsiveness to therapies, in order to perform a tailored nutritional intervention as an integral part of the treatment of patients with COVID-19. The aim of this study was to review the current data on the relevance of nutritional status, including trace elements and vitamin status, in influencing the course and outcome of the disease 3 mo after the World Health Organization's declaration of COVID-19 as a pandemic.

Neda Valian

Rivka Gelman, Jillian Whelan, Sheree Spiteri et al.

Abstract Background Instilling healthy dietary habits and active play in early childhood is an important public health focus. Interventions supporting the establishment of nutrition and active play behaviours in the first years of life have shown positive outcomes and long-term cost-effectiveness, however, most are research trials, with limited evidence regarding real-world application. Implementation science theories, models and frameworks (TMFs) can guide the process of research translation from trial to real-world intervention. The application of TMFs within nutrition and active play intervention studies in early childhood (< 5 years) is currently unknown. This systematic review identified the use of TMFs and barriers/ enablers associated with intervention adoption, implementation, and sustainability in early childhood nutrition and active play interventions implemented under real-world conditions. Methods Six databases were searched for peer-reviewed publications between 2000–2021. Studies were included if primary outcomes reported improvement in diet, physical activity or sedentary behaviours amongst children aged < 5 years and interventions were delivered under real-world conditions within a community and/or healthcare setting. Two reviewers extracted and evaluated studies, cross checked by a third and verified by all authors. Quality assessment of included studies was completed by two authors using the Mixed Methods Appraisal Tool (MMAT). Results Eleven studies comprising eleven unique interventions were included. Studies represented low, middle and high-income countries, and were conducted across a range of settings. Five TMFs were identified representing four of Nilsen’s implementation model categories, predominantly ‘evaluation models’. Ninety-nine barriers/facilitators were extracted across the three intervention phases—Implementation (n = 33 barriers; 33 facilitators), Sustainability (n = 19 barriers; n = 9 facilitators), Adoption (n = 2 barriers; n = 3 facilitators). Identified barriers/facilitators were mapped to the five domains of the Durlak and DuPre framework, with ‘funding’, ‘compatibility’ and ‘integration of new programming’ common across the three intervention phases. Conclusions Findings demonstrate that there is no systematic application of TMFs in the planning, implementation and/or evaluation of early childhood nutrition and active play interventions in real-world settings, and selective and sporadic application of TMFs occurs across the intervention lifespan. This apparent limited uptake of TMFs is a missed opportunity to enhance real-world implementation success. Trial registration PROSPERO (CRD42021243841).

Hnin Wai Lwin Myo, Akiko S Hosler, Lawrence M Schell et al.

Abstract Objective: The Burmese population is one of the fast-growing refugee populations in the USA. This study investigated behavioural and environmental factors associated with fruit and vegetable (FV) consumption among Burmese refugees. Design: We conducted a cross-sectional interview survey in 2018–2019. The 24-h recall was used to assess dietary behaviour. Multivariable logistic regression models were constructed with meeting the daily FV consumption recommendation (two or more servings of fruits and three or more servings of vegetables) as the outcome variable. We selected socio-economics, nutritional knowledge, food shopping frequency, ethnicity of preferred food store owners, perceived neighbourhood food environment and network distance to preferred food stores as potential explanatory variables. Setting: Two Upstate New York counties. Participants: Burmese refugees (n 173) aged ≥18 years. Results: Forty-five percentage of respondents met the daily FV consumption recommendation, and nearly all respondents identified ethnic (Burmese, Chinese/pan-Asian, or South Asian/halal) stores as their preferred stores to purchase FV. In the best-fit model, age (OR 1·08, 95 % CI (1·04, 1·12)) and shopping frequency (OR 1·51, 95 % CI (1·01, 2·26)) were positively associated, and network distance to preferred stores in kilometres (OR 0·81, 95 % CI (0·73, 0·90)) was negatively associated with meeting the daily FV consumption recommendation. No significant effect modifications by car ownership, poverty, length of stay in the USA and Supplemental Nutrition Assistance Program participation were detected. Conclusions: The findings suggested that having Asian ethnic food stores within a short, walkable distance from home and shopping at these stores often can promote healthy dietary behaviour among Burmese refugees.

A. Licata, Maddalena Zerbo, Silvia Como et al.

Over the past few years, growing interest has been shown for the impact of dietary requirements and nutritional factors on chronic diseases. As a result, nutritional programs have been reinforced by public health policies. The precise role of micronutrients in chronic liver disease is currently receiving particular attention since abnormalities in vitamin levels are often detected. At present, treatment programs are focused on correcting vitamin deficiencies, which are frequently correlated to higher rates of comorbidities with poor outcomes. The literature reviewed here indicates that liver diseases are often related to vitamin disorders, due to both liver impairment and abnormal intake. More specific knowledge about the role of vitamins in liver disease is currently emerging from various results and recent evidence. The most significant benefits in this area may be observed when improved vitamin intake is combined with a pharmacological treatment that may also affect the progression of the liver disease, especially in the case of liver tumors. However, further studies are needed.

A. Joharapurkar, V. Pandya, V. Patel et al.

Jun Huang, Li Li, Li Fan et al.

Abstract Background In order to evaluate right ventricular (RV) systolic and diastolic dysfunctions in patients with type 2 diabetes mellitus (T2DM) with poor glycemic control by layer specific global longitudinal strain (GLS) and strain rate (GLSr). Methods 68 T2DM patients and 66 normal controls were enrolled for the present study. RV layer specific GLS (GLSEpi, GLSMid and GLSEndo represent the epimyocardial, middle layer and endomyocardial strains, respectively) and GLSr (GLSr-S, GLSr-E and GLSr-A represent the systole, early-diastole and late-diastole strain rate) were calculated by averaging each of the three regional peak systolic strains and strain rates along the entire RV free-wall (RVFW), entire RV free-wall and septal wall (RVFSW) on RV-focused view. Results The absolute values of RV layer specific GLS (GLSEpi, GLSMid and GLSEndo) in RVFW in T2DM patients were significantly lower than normal controls (P < 0.01), while GLSr-A was significantly larger than normal controls (P < 0.001). The absolute values of RV layer specific GLS (GLSEpi and GLSMid) in RVFSW in T2DM patients were significantly lower than normal controls (P < 0.05), while GLSr-A was significantly larger than normal controls (P < 0.001). HbA1c were poor negatived correlated with GLSEpi in RVFW and RVFSW in T2DM patients (P < 0.05). ROC analysis showed that RV layer specific GLS and GLSr-A had a high diagnostic efficacy in T2DM patients, and GLSr-A in RVFSW have the best diagnostic value in RV diastolic function in T2DM patients (AUC: 0.773). Conclusion From the research, we found that layer specific GLS and GLSr could detect the RV myocardial dysfunctions and confirmed that the impaired RV systolic and diastole functions in T2DM patients with poor glycemic control. GLSr-A in RVFSW had the best diagnostic value in evaluating RV diastolic function in T2DM patients.

K. Katayama

The capacity to metabolize proteins is closely related to the hepatic functional reserve in patients with chronic liver disease, and hypoalbuminemia and hyperammonemia develop along with hepatic disease progression. Zinc deficiency, which is frequently observed in patients with chronic liver disease, significantly affects protein metabolism. Ornithine transcarbamylase is a zinc enzyme involved in the urea cycle. Its activity decreases because of zinc deficiency, thereby reducing hepatic capacity to metabolize ammonia. Because the glutamine-synthesizing system in skeletal muscles compensates for the decrease in ammonia metabolism, hyperammonemia does not develop in the early stages of chronic liver disease. However, branched-chain amino acids (BCAAs) are consumed with the increase in glutamine-synthesizing system reactions, leading to a decreased capacity to synthesize proteins, including albumin, due to amino acid imbalance. Upon further disease progression, skeletal muscle mass decreases because of nutritional deficiency, as well as the further decreased capacity to metabolize ammonia in the liver, whereby the capacity to detoxify ammonia reduces as a whole, resulting in hyperammonemia. BCAA supplementation therapy for nutritional deficiency in liver cirrhosis improves survival by correcting amino acid imbalance via recovery of the capacity to synthesize albumin, while zinc supplementation therapy improves the capacity to metabolize ammonia in the liver. Here, the efficacy of a combination of BCAA and zinc preparation for nutritional deficiency in liver cirrhosis, as well as its theoretical background, was reviewed.

E. Mammadova-Bach, A. Braun

Zn2+ deficiency in the human population is frequent in underdeveloped countries. Worldwide, approximatively 2 billion people consume Zn2+-deficient diets, accounting for 1–4% of deaths each year, mainly in infants with a compromised immune system. Depending on the severity of Zn2+ deficiency, clinical symptoms are associated with impaired wound healing, alopecia, diarrhea, poor growth, dysfunction of the immune and nervous system with congenital abnormalities and bleeding disorders. Poor nutritional Zn2+ status in patients with metastatic squamous cell carcinoma or with advanced non-Hodgkin lymphoma, was accompanied by cutaneous bleeding and platelet dysfunction. Forcing Zn2+ uptake in the gut using different nutritional supplementation of Zn2+ could ameliorate many of these pathological symptoms in humans. Feeding adult rodents with a low Zn2+ diet caused poor platelet aggregation and increased bleeding tendency, thereby attracting great scientific interest in investigating the role of Zn2+ in hemostasis. Storage protein metallothionein maintains or releases Zn2+ in the cytoplasm, and the dynamic change of this cytoplasmic Zn2+ pool is regulated by the redox status of the cell. An increase of labile Zn2+ pool can be toxic for the cells, and therefore cytoplasmic Zn2+ levels are tightly regulated by several Zn2+ transporters located on the cell surface and also on the intracellular membrane of Zn2+ storage organelles, such as secretory vesicles, endoplasmic reticulum or Golgi apparatus. Although Zn2+ is a critical cofactor for more than 2000 transcription factors and 300 enzymes, regulating cell differentiation, proliferation, and basic metabolic functions of the cells, the molecular mechanisms of Zn2+ transport and the physiological role of Zn2+ store in megakaryocyte and platelet function remain elusive. In this review, we summarize the contribution of extracellular or intracellular Zn2+ to megakaryocyte and platelet function and discuss the consequences of dysregulated Zn2+ homeostasis in platelet-related diseases by focusing on thrombosis, ischemic stroke and storage pool diseases.